Skip to main content
ACI logo

ACI · Albertsons Companies, Inc.

Track ACI — free
$11.61 -0.03 (-0.26%) At close · Sep 30
Market Cap
$5.66B
Shares
485.33M
Volume · Sep 30 7.61M Avg daily vol (3M) 8.25M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$11.61 Open$11.81 Day$11.55–11.83 52W close$11.03–19.74 Avg vol 30d7.4M Short int56.0M · 11.5% float · 6.6d Short vol66% Last earningsOct 13, 2026 DataJun 2020–Sep 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 13, 2026 Scheduled · in 2 wks
filed Jul 28, 2026
call held Jul 23, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+1.9%
Year over year
Operating margin
0.9%
Trailing 12 months
P / E (TTM)
11.1
Trailing earnings · reciprocal yield 9.0%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-8.5%
Year over year · fewer shares
Price change (1Y)
-33.4%
Trailing year
Short interest
11.5%
Latest settlement · 6.6 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol High
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −25%
below
Price vs 50-day avg −4%
below
RSI (14) 39
neutral
MACD trend Negative
52-week position 7%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −7%
trailing
6-month return −34%
trailing
YTD return −32%
this year
Relative strength −47%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $12 › 200d $15 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +81 funds added
Insider flow Accumulating
Net +$2.5M over 90 days · 0% sells
Short interest Rising
11.53% of float · ▲ +2.8% MoM · 6.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
448 holders — mid 3-yr range
Squeeze score 64
elevated · 0–100
Fundamentals
Fair
Revenue growth +3%
Y/Y
Gross margin 27%
contracting
EPS growth −76%
Y/Y
Free cash flow $723.5M
Buyback $2.0B
remaining
Balance sheet $8.9B
net debt
Quant / Vol
risk profile
High
Volatility 39%
annualized · 1-yr
Max drawdown −44%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 23, 2026
Identical sales excluding pharmacy IRA · fiscal 26 Initiated 0% – 1%
Adjusted EBITDA · fiscal 26 Non-GAAP Initiated $3.55B – $3.63B
Adjusted EPS · fiscal 26 Non-GAAP Initiated $1.75 – $1.85
Capital expenditures · fiscal 26 Initiated $1.9B – $2B

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−25% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
39 Neutral
MACD trend
Negative Bearish
52-week position
7% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $12 › 200d $15 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +81 funds added
Insider flow Accumulating
Net +$2.5M over 90 days · 0% sells
Short interest Rising
11.53% of float · ▲ +2.8% MoM · 6.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
448 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $11 Now $12 · 7% Range high $20
vs 200-day avg -25% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $1.01B the first quarter of fiscal 2026 filing —
Adjusted net income non-GAAP $210.3M the first quarter of fiscal 2026 filing —
Adjusted net income per Class A common share non-GAAP $0.42 first quarter of fiscal 2026 filing —
Capital expenditures $522M first quarter of fiscal 2026 filing —
Digital sales 13% first quarter of fiscal 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Grocery Stores — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ACI
Albertsons Companies, Inc.
this stock
$5.66B -32.4% +3.5% — 11.5%
KR
Kroger Co
$34.69B -2.7% +0.4% 32.2 5.0%
SVNDF
Seven & I Holdings Co Ltd
$29.49B -12.6% — — 0.4%
CRRFY
Carrefour SA
$12.95B +11.1% — — 0.0%
DNOPF
Dino Polska S.A./ADR
$9.24B -18.1% — — 0.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
448
% held
95.9%
Net QoQ
+7.5M sh
Top holder
Cerberus Capital Manageme…
Held Float
View
Held by Funds
Fund positions
396
View
Short & Settlement
Short Interest Rising
Shares short
56.0M
Days to cover
6.6d
Change
+1.5M sh
View
Short Volume
Short vol %
66%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$12
As of
Sep 10, 2026
View
Off-Exchange
Off-exchange %
37.1%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$2.5M
Buyers / Sellers
3 / 0
Buyers Sellers
View
Congressional Trades Buy
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Sep 11, 2025
View
Financials
Financials
Revenue (FY)
$83.2B
Net income (FY)
$217.4M
EPS diluted
$0.40
View
Buybacks
Authorized
$2.8B
Remaining
$2.0B
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 30, 2026
This year
14
View
Proposed Sales
Value
$310.4K
Shares
19.4K
Filed
May 6, 2026
View
Earnings & Events
Earnings Calls Upcoming
Next call
Oct 13, 2026
Last call
Jul 23, 2026
View
Investor Relations
Latest news
American Pharmacists Month Starts…
Published
Sep 30, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
ACI -0.8% -6.8% -33.5% -6.0% -32.4%
SPY -1.2% -0.4% +13.1% -0.4% +12.1%
vs SPY +0.4% -6.5% -46.6% -5.6% -44.5%

Capital returns

Buyback program · as of Apr 14, 2026
Authorized
$2.75B
Spent (derived)
$750.00M
Remaining
$2.00B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1646972 CUSIP 013091103 13F (30d) 10 filings 8 filers Visit website Investor relations